Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 8 |
NetGPI | no | yes: 0, no: 8 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005739 | mitochondrion | 5 | 1 |
GO:0005741 | mitochondrial outer membrane | 5 | 1 |
GO:0016020 | membrane | 2 | 7 |
GO:0019867 | outer membrane | 3 | 1 |
GO:0031090 | organelle membrane | 3 | 1 |
GO:0031966 | mitochondrial membrane | 4 | 1 |
GO:0031968 | organelle outer membrane | 4 | 1 |
GO:0043226 | organelle | 2 | 1 |
GO:0043227 | membrane-bounded organelle | 3 | 1 |
GO:0043229 | intracellular organelle | 3 | 1 |
GO:0043231 | intracellular membrane-bounded organelle | 4 | 1 |
GO:0098588 | bounding membrane of organelle | 4 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 7 |
Related structures:
AlphaFold database: A4IBD2
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 14 | 18 | PF00656 | 0.675 |
CLV_C14_Caspase3-7 | 26 | 30 | PF00656 | 0.698 |
CLV_NRD_NRD_1 | 147 | 149 | PF00675 | 0.550 |
CLV_NRD_NRD_1 | 158 | 160 | PF00675 | 0.569 |
CLV_NRD_NRD_1 | 234 | 236 | PF00675 | 0.398 |
CLV_NRD_NRD_1 | 260 | 262 | PF00675 | 0.598 |
CLV_NRD_NRD_1 | 36 | 38 | PF00675 | 0.495 |
CLV_PCSK_FUR_1 | 42 | 46 | PF00082 | 0.324 |
CLV_PCSK_KEX2_1 | 158 | 160 | PF00082 | 0.569 |
CLV_PCSK_KEX2_1 | 234 | 236 | PF00082 | 0.398 |
CLV_PCSK_KEX2_1 | 36 | 38 | PF00082 | 0.428 |
CLV_PCSK_KEX2_1 | 41 | 43 | PF00082 | 0.407 |
CLV_PCSK_KEX2_1 | 44 | 46 | PF00082 | 0.380 |
CLV_PCSK_PC1ET2_1 | 41 | 43 | PF00082 | 0.373 |
CLV_PCSK_PC1ET2_1 | 44 | 46 | PF00082 | 0.357 |
CLV_PCSK_PC7_1 | 37 | 43 | PF00082 | 0.419 |
CLV_PCSK_SKI1_1 | 180 | 184 | PF00082 | 0.664 |
DEG_APCC_DBOX_1 | 147 | 155 | PF00400 | 0.321 |
DEG_APCC_DBOX_1 | 234 | 242 | PF00400 | 0.647 |
DEG_APCC_DBOX_1 | 44 | 52 | PF00400 | 0.479 |
DOC_CYCLIN_RxL_1 | 33 | 43 | PF00134 | 0.682 |
DOC_USP7_MATH_1 | 165 | 169 | PF00917 | 0.364 |
DOC_USP7_MATH_1 | 242 | 246 | PF00917 | 0.662 |
LIG_14-3-3_CanoR_1 | 174 | 183 | PF00244 | 0.408 |
LIG_14-3-3_CanoR_1 | 79 | 85 | PF00244 | 0.404 |
LIG_14-3-3_CanoR_1 | 89 | 97 | PF00244 | 0.382 |
LIG_APCC_ABBA_1 | 72 | 77 | PF00400 | 0.374 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.710 |
LIG_BRCT_BRCA1_1 | 178 | 182 | PF00533 | 0.466 |
LIG_deltaCOP1_diTrp_1 | 111 | 121 | PF00928 | 0.571 |
LIG_FHA_1 | 124 | 130 | PF00498 | 0.606 |
LIG_FHA_1 | 135 | 141 | PF00498 | 0.307 |
LIG_FHA_1 | 187 | 193 | PF00498 | 0.391 |
LIG_FHA_1 | 89 | 95 | PF00498 | 0.382 |
LIG_FHA_2 | 12 | 18 | PF00498 | 0.689 |
LIG_LIR_Gen_1 | 91 | 101 | PF02991 | 0.440 |
LIG_LIR_Nem_3 | 91 | 96 | PF02991 | 0.440 |
LIG_SH2_CRK | 53 | 57 | PF00017 | 0.394 |
LIG_SH2_STAT5 | 107 | 110 | PF00017 | 0.408 |
LIG_SH2_STAT5 | 216 | 219 | PF00017 | 0.555 |
LIG_SH2_STAT5 | 82 | 85 | PF00017 | 0.391 |
LIG_SH3_1 | 164 | 170 | PF00018 | 0.384 |
LIG_SH3_3 | 164 | 170 | PF00018 | 0.384 |
LIG_SH3_3 | 248 | 254 | PF00018 | 0.805 |
LIG_SH3_4 | 253 | 260 | PF00018 | 0.814 |
LIG_SUMO_SIM_anti_2 | 6 | 14 | PF11976 | 0.632 |
LIG_TRAF2_1 | 255 | 258 | PF00917 | 0.727 |
LIG_TYR_ITIM | 51 | 56 | PF00017 | 0.437 |
MOD_CK1_1 | 6 | 12 | PF00069 | 0.577 |
MOD_CK2_1 | 175 | 181 | PF00069 | 0.531 |
MOD_Cter_Amidation | 156 | 159 | PF01082 | 0.439 |
MOD_GlcNHglycan | 154 | 157 | PF01048 | 0.450 |
MOD_GlcNHglycan | 192 | 195 | PF01048 | 0.337 |
MOD_GlcNHglycan | 196 | 199 | PF01048 | 0.337 |
MOD_GlcNHglycan | 210 | 213 | PF01048 | 0.450 |
MOD_GlcNHglycan | 246 | 249 | PF01048 | 0.681 |
MOD_GSK3_1 | 113 | 120 | PF00069 | 0.557 |
MOD_GSK3_1 | 181 | 188 | PF00069 | 0.452 |
MOD_GSK3_1 | 190 | 197 | PF00069 | 0.309 |
MOD_GSK3_1 | 20 | 27 | PF00069 | 0.595 |
MOD_GSK3_1 | 204 | 211 | PF00069 | 0.391 |
MOD_GSK3_1 | 6 | 13 | PF00069 | 0.570 |
MOD_GSK3_1 | 63 | 70 | PF00069 | 0.405 |
MOD_N-GLC_1 | 80 | 85 | PF02516 | 0.488 |
MOD_NEK2_1 | 11 | 16 | PF00069 | 0.505 |
MOD_NEK2_1 | 113 | 118 | PF00069 | 0.542 |
MOD_NEK2_1 | 175 | 180 | PF00069 | 0.554 |
MOD_NEK2_1 | 186 | 191 | PF00069 | 0.379 |
MOD_NEK2_1 | 208 | 213 | PF00069 | 0.575 |
MOD_NEK2_1 | 3 | 8 | PF00069 | 0.530 |
MOD_NEK2_1 | 56 | 61 | PF00069 | 0.331 |
MOD_NEK2_1 | 63 | 68 | PF00069 | 0.318 |
MOD_NEK2_1 | 75 | 80 | PF00069 | 0.338 |
MOD_NEK2_1 | 88 | 93 | PF00069 | 0.416 |
MOD_NEK2_2 | 101 | 106 | PF00069 | 0.437 |
MOD_PK_1 | 20 | 26 | PF00069 | 0.621 |
MOD_PKA_2 | 176 | 182 | PF00069 | 0.600 |
MOD_PKA_2 | 6 | 12 | PF00069 | 0.608 |
MOD_PKA_2 | 88 | 94 | PF00069 | 0.468 |
MOD_Plk_1 | 3 | 9 | PF00069 | 0.642 |
MOD_Plk_1 | 80 | 86 | PF00069 | 0.478 |
MOD_Plk_4 | 186 | 192 | PF00069 | 0.534 |
MOD_Plk_4 | 27 | 33 | PF00069 | 0.601 |
MOD_Plk_4 | 70 | 76 | PF00069 | 0.567 |
MOD_SUMO_for_1 | 40 | 43 | PF00179 | 0.545 |
TRG_DiLeu_BaLyEn_6 | 149 | 154 | PF01217 | 0.482 |
TRG_DiLeu_BaLyEn_6 | 171 | 176 | PF01217 | 0.581 |
TRG_ENDOCYTIC_2 | 216 | 219 | PF00928 | 0.422 |
TRG_ENDOCYTIC_2 | 227 | 230 | PF00928 | 0.442 |
TRG_ENDOCYTIC_2 | 53 | 56 | PF00928 | 0.394 |
TRG_ER_diArg_1 | 158 | 160 | PF00400 | 0.456 |
TRG_ER_diArg_1 | 233 | 235 | PF00400 | 0.435 |
TRG_ER_diArg_1 | 36 | 38 | PF00400 | 0.633 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8R5 | Leptomonas seymouri | 77% | 100% |
A0A1X0P5Q2 | Trypanosomatidae | 58% | 100% |
A0A3Q8IJ41 | Leishmania donovani | 100% | 100% |
C9ZZ87 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 56% | 100% |
E9AF88 | Leishmania major | 94% | 100% |
E9B6E3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
V5C312 | Trypanosoma cruzi | 58% | 100% |